Keurig Dr Pepper is trading at $34.69, down 5.80%, after management reaffirmed, rather than raised, its full-year outlook.

  • November 3, 2026 results beat earnings and revenue expectations.
  • Management reaffirmed 2026 sales guidance of $25.9–$26.4 billion and low-double-digit adjusted EPS growth.
  • Reuters reported quarterly gross margin fell to 48% from 54.3%, citing inflation and higher marketing expenses, and noted revised expectations for legacy U.S. Coffee; defensive-sector strength is not offsetting the decline.